Wordt geladen...
Once-weekly albiglutide in the management of type 2 diabetes: patient considerations
This review describes the pharmacologic, pharmacokinetic, and pharmacodynamic properties of albiglutide, as well as its clinical efficacy and safety. Albiglutide is a novel, once-weekly, injectable glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes. The European Commission...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4049886/ https://ncbi.nlm.nih.gov/pubmed/24926194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S53075 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|